Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KP1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $86,170
Award facts
- Contract value 100% obligated
- $86,170.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $86,170.27 to Amerisourcebergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2mL pen format. This contract, awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, represents a firm fixed-price procurement with no set-aside designation. The award falls under a competitive delivery order mechanism, reflecting DLA's open competition procurement practices for pharmaceutical supplies. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is ultimately owned by parent company Cencora, Inc. (doing business as Amerisourcebergen).
This delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical contract vehicle enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other federal health systems. Cosentyx, a specialty immunosuppressant medication, represents the type of advanced pharmaceutical product DLA procures through this vehicle to meet the therapeutic needs of military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9KP1?
SPE2DR26F9KP1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KP1 worth?
The government has obligated $86,170 on SPE2DR26F9KP1.
Is contract SPE2DR26F9KP1 an order under another contract?
Yes. SPE2DR26F9KP1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KP1 competed?
The extent of competition for SPE2DR26F9KP1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award